MARI, Rosella
 Distribuzione geografica
Continente #
NA - Nord America 1.753
EU - Europa 466
AS - Asia 437
OC - Oceania 3
AF - Africa 1
SA - Sud America 1
Totale 2.661
Nazione #
US - Stati Uniti d'America 1.747
CN - Cina 224
SG - Singapore 120
UA - Ucraina 114
DE - Germania 87
IT - Italia 86
TR - Turchia 72
GB - Regno Unito 51
SE - Svezia 41
FI - Finlandia 34
PL - Polonia 20
BE - Belgio 15
CA - Canada 6
ID - Indonesia 6
CZ - Repubblica Ceca 5
VN - Vietnam 4
IL - Israele 3
AU - Australia 2
FR - Francia 2
JP - Giappone 2
LT - Lituania 2
NL - Olanda 2
PT - Portogallo 2
AT - Austria 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BR - Brasile 1
CH - Svizzera 1
EG - Egitto 1
IE - Irlanda 1
IQ - Iraq 1
IR - Iran 1
JO - Giordania 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
RU - Federazione Russa 1
TH - Thailandia 1
Totale 2.661
Città #
Woodbridge 236
Chandler 196
Fairfield 150
Jacksonville 146
Ann Arbor 140
Santa Clara 108
Singapore 99
Ashburn 89
Wilmington 75
Houston 72
Seattle 60
Beijing 55
Cambridge 45
Izmir 44
Nanjing 44
Shanghai 31
Ferrara 30
Princeton 29
Boardman 23
New York 21
Warsaw 20
Dearborn 17
Milan 16
Nanchang 16
Brussels 15
Shenyang 14
Changsha 13
San Diego 13
Bremen 8
Mountain View 8
Des Moines 7
Helsinki 7
Hebei 6
Jakarta 6
London 6
Monmouth Junction 6
Norwalk 6
Redwood City 6
Tianjin 6
Auburn Hills 5
Brno 5
Jiaxing 5
Jinan 5
Los Angeles 5
Munich 5
Toronto 5
Dong Ket 4
Frankfurt am Main 4
Guangzhou 4
Kunming 4
Düsseldorf 3
Orange 3
Sheffield 3
Tel Aviv 3
Augusta 2
Bologna 2
Hefei 2
Inzago 2
Leawood 2
Portici 2
San Mateo 2
Yellow Springs 2
Abano Terme 1
Addison 1
Amman 1
Anzola Dell'emilia 1
Apo 1
Ardabil 1
Asahi 1
Auckland 1
Baku 1
Bangkok 1
Boxborough 1
Brierley Hill 1
Cairo 1
Chicago 1
Dortmund 1
Dublin 1
Emden 1
Falls Church 1
Forest City 1
Fuzhou 1
Genoa 1
Haikou 1
Imola 1
Jesi 1
Leipzig 1
Lisbon 1
Melbourne 1
Memphis 1
Milford 1
Montegrotto Terme 1
Ningbo 1
Oslo 1
Ottawa 1
Paris 1
Perth 1
Poulsbo 1
Pregassona 1
San Francisco 1
Totale 2.006
Nome #
An exon-specific U1snRNA induces a robust factor IX activity in mice expressing multiple human FIX splicing mutants 185
Differential functional readthrough over homozygous nonsense mutations contributes to the bleeding phenotype in coagulation factor VII deficiency 175
Coagulation factor XIIIA (F13A1): Novel perspectives in treatment and pharmacogenetics 137
Coexistence of antithrombin deficiency, factor V Leiden and hyperhomocysteinemia in a thrombotic family. 136
Factor XIII-A dynamics in acute myocardial infarction: a novel prognostic biomarker? 132
The carboxyl-terminal region is not essential for secreted and functional levels of coagulation factor X 123
Coagulation Factor XII Levels and Intrinsic Thrombin Generation in Multiple Sclerosis 118
FXIII levels and genotypes in myocardial infarction: a potential novel prognostic biomarker? 103
Replacement of the Y450 (c234) phenyl ring in the carboxyl-terminal region of coagulation factor IX causes pleiotropic effects on secretion and enzyme activity 100
C677T/A1298C MTHFR Gene Mutations, Homocysteine, Folate Levels and MTHFR Activity, in Normal Subjects and Cases with Myocardial Infarction 97
null 91
Una "rete" per proteggere il cuore. (FAR 2013) 90
null 80
A modified functional Global test to measure PC, PS activities and the APC-Resistance phenotype. 80
Factor XIII-A Gene Mutation (Val34Leu) and Arterial Vascular Disease 79
Resistance to activated protein C and low levels of protein S activity in nine thrombophilic families: a correct diagnosis. 74
Dihydrofolate reductase (DHFR) 19-bp ins/del polymorphism and methylenetetrahydrofolate reductase (MTHFR) C677T in coronary heart disease patients: potential intracellular folate unbalancing. 74
FXIII Levels in Myocardial Infarction: a Potential Novel Prognostic Biomarker? 74
Effect of factor XIII Val34Leu polymorphism on plasma clot formation: crosslinking functions and clot longevity properties. 72
Factor V Levels in a Cohort of Patients Eligible for Oral Anticoagulant Therapy. 71
Coexistence of antitrhombin deficency, factor V Leiden and hereditary hyperhomocyst(e)inemia in a thrombotic family. 70
Thrombotic risk in thalassemic patients. 67
Differente risposta alla Proteina C attivata della muatazione R506Q del fattore V della coagulazione (FV Leiden) in due generazioni della stessa famiglia. 59
Low folate levels and thermolabile MTHFR as primary determinant of mild Hyperhomocysteinemia in normal and thromboembolic subjects. 58
MTHFR C677T/A1298C, MS A2756G and MTRR A66G Gene Polymorphisms: Effects on Homocysteine Levels and Risk of Miocardial Infarction 55
Low Sensitivity to Endogenous Activated Protein C in Protein S Deficient Subjects Reflects a Reduction in the Thrombotic Risk 54
Determinazione dell’anticoagulante lupico (LAC) con un metodo al caolino automatizzato. 51
Readthrough-mediated functional suppression of homozygous nonsense mutations accounts for variable bleeding phenotypes in factor VII deficiency 49
null 42
Rescue of coagulation factor VII mRNA processing and protein function by engineered U1+5A snRNA 40
The G to T Point Mutation (Val34Leu) in the Factor XIII-A Subunit Gene in Venous Leg Ulcers 37
Different anticoagulant response to activated protein C (APC-test) and to Agkistrodon Contortix Venom (ACV-test) in a family with FV-R506Q substitution 30
Totale 2.703
Categoria #
all - tutte 12.389
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.389


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020274 0 0 0 0 0 67 40 40 32 54 35 6
2020/2021352 34 19 7 37 11 32 27 42 12 60 56 15
2021/2022272 7 24 9 22 13 8 14 20 3 29 36 87
2022/2023401 37 46 7 58 65 52 21 35 45 1 18 16
2023/2024171 15 17 6 2 17 35 11 25 7 0 1 35
2024/2025291 20 18 61 24 104 64 0 0 0 0 0 0
Totale 2.703